Singapore markets closed

Fulcrum Therapeutics, Inc. (FULC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.73-0.33 (-4.67%)
As of 03:07PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,805
2,805
6,342
19,163
8,823
Operating expenses
Research development
71,801
71,801
76,782
69,701
59,042
Selling general and administrative
41,668
41,668
41,694
30,516
21,392
Total operating expenses
113,469
113,469
118,476
100,217
80,434
Operating income or loss
-110,664
-110,664
-112,134
-81,054
-71,611
Total other income/expenses net
13,329
13,329
2,263
207
792
Income before tax
-97,335
-97,335
-109,871
-80,847
-70,819
Income from continuing operations
-97,335
-97,335
-109,871
-80,847
-70,819
Net income
-97,335
-97,335
-109,871
-80,847
-70,819
Net income available to common shareholders
-97,335
-97,335
-109,871
-80,847
-70,819
Basic EPS
-1.66
-
-2.44
-2.29
-2.79
Diluted EPS
-1.66
-
-2.44
-2.29
-2.79
Basic average shares
58,880
-
44,991
35,361
25,354
Diluted average shares
58,880
-
44,991
35,361
25,354